Clinical Trial Update: The Impact of Oxidative Stress on Erythrocyte Biology [Phase 2]

View source ↗

Summary

A Phase 2 trial examining the impact of oxidative stress on erythrocyte biology in sickle cell disease was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Sickle Cell Disease Without Crisis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-03